eduKate Learning Manual
Science | Veterinary World
Understand → Compare → Model → Explain → Test → Go Deeper

Species-Specific Pharmacology

Why the Same mg/kg Dose Is Not the Same Drug Experience Across Animals

Wait, What? Dividing by Body Weight Does Not Make a Drug Universal

Suppose two animals receive the same amount of a substance for every kilogram of body mass.

It is tempting to think the dose has now been “made fair.”

But a kilogram of cat is not a kilogram of dog with different fur. A kilogram of horse tissue does not necessarily absorb, distribute, transform, respond to and eliminate a molecule in the same way as a kilogram of bird, rabbit or fish.

same mg/kg ≠ same concentration over time ≠ same receptor effect ≠ same safety.

This is one of the central problems of veterinary pharmacology.

The Scientific Job

This manual owns a specific veterinary question:

Why can the same drug behave differently across animal species even after dose is adjusted for body mass?

The job is not to recommend medicines or doses. It is to explain the comparative biology that makes veterinary drug science intrinsically species-specific.

Quick Answer

A drug response depends on at least two linked systems:

pharmacokinetics: what the animal’s body does to the drug;
pharmacodynamics: what the drug does to the animal’s body or to a microorganism or parasite within it.

Species can differ in gut anatomy, gastric pH, body-water distribution, plasma proteins, liver enzymes, kidney handling, transporters, receptors, temperature, metabolic rate and many other variables. Those differences can alter both exposure and effect.

Part 1 — Follow the Molecule

A useful pharmacokinetic model is often summarised as ADME:

Absorption — how the substance enters the bloodstream;
Distribution — where it travels in body fluids and tissues;
Metabolism — how enzymes chemically transform it;
Excretion — how it and its metabolites leave the body.

Each step can vary between species.

dose given → absorption → blood concentration → tissue distribution → metabolism → elimination → concentration over time.

Part 2 — Absorption Is Already a Comparative-Anatomy Problem

An oral drug enters a digestive system whose architecture may be dramatically different across species.

Ruminants have a large fermentation system before the true stomach. Horses are hindgut fermenters. Rabbits have specialised hindgut physiology and cecotrophy. Birds lack mammalian dental processing and have specialised digestive structures. Fish may receive medicines through water or feed in an aquatic environment.

Transit time, food, pH, microbial metabolism and formulation can therefore influence how much drug reaches the circulation.

Part 3 — Distribution Depends on the Body the Molecule Enters

Once in the bloodstream, a molecule may remain dissolved, bind to plasma proteins, enter extracellular fluid, cross cell membranes, accumulate in fat or reach specialised compartments.

Body composition and protein binding influence the apparent volume into which a drug distributes. A neonate, dehydrated animal, obese animal and adult lean animal of the same species may already differ. Across species the variation becomes larger.

Part 4 — Metabolism Can Change the Entire Safety Story

The liver contains enzyme systems that transform many chemicals. Metabolism can make a compound easier to eliminate, activate an inactive precursor, deactivate an active drug or generate a more reactive metabolite.

Species do not carry identical complements or activities of all metabolic pathways.

A famous veterinary example is the cat’s limited capacity for some glucuronidation reactions. This contributes to extreme susceptibility to certain compounds that other species handle differently. The lesson is broader than one medicine:

species-specific enzyme capacity can turn an ordinary exposure in one species into a toxic exposure in another.

Explore the Merck Veterinary Manual discussion of species differences in human-analgesic toxicosis →

Part 5 — Elimination Determines How Long Exposure Persists

Kidneys filter blood, secrete some substances into tubules and reabsorb others. Liver and bile can also contribute to elimination. Renal function, urine chemistry, transport proteins and biliary pathways differ among animals and can change with age or disease.

If elimination is slower, a compound may remain in the body longer. With repeated exposure, concentrations can accumulate.

Part 6 — Half-Life Is a Time Question

Pharmacologists often describe how quickly concentration falls using half-life: the time required for a measured concentration or amount to decrease by half under defined conditions.

A longer half-life can mean longer persistence. But half-life is not a universal property of the molecule alone. It emerges from the molecule interacting with a particular body.

drug property + animal physiology = observed pharmacokinetic behaviour.

Part 7 — Pharmacodynamics: Same Concentration, Different Effect

Even if two species somehow achieved the same tissue concentration, they might not show the same biological response.

Drugs act through receptors, enzymes, ion channels, transporters, microbial targets and other molecular systems. Receptor abundance, receptor affinity, signal-transduction pathways and tissue physiology can differ across species.

This is pharmacodynamics: the relationship between concentration and biological effect.

Explore Merck Veterinary Manual pharmacodynamics →

Part 8 — Body Weight Is Useful, but It Is Not the Whole Model

Scaling dose to body mass is often biologically sensible because a larger body may contain a larger distribution volume or require more total drug to achieve a target exposure.

But body mass does not directly encode liver-enzyme activity, receptor sensitivity, gut anatomy or kidney transport.

A mg/kg expression therefore standardises one dimension while leaving many others unresolved.

Part 9 — Allometry: When Biology Scales Non-Linearly

Many biological rates do not scale perfectly in direct proportion to body mass. Metabolic rate, organ blood flow and physiological time can follow non-linear scaling relationships across animals of very different size.

Allometric models can help scientists explore cross-species scaling, but they are not magic conversion formulas. A model built across mammals may fail when transporter biology, metabolism or target sensitivity differs sharply.

Part 10 — Disease Changes Pharmacology Too

Species is only the first layer. Liver disease can change metabolism. Kidney disease can change elimination. Dehydration can alter distribution and renal perfusion. Low plasma proteins can change the free fraction of protein-bound compounds.

That is why pharmacokinetic models based on healthy animals do not automatically predict every patient.

Explore Merck Veterinary Manual pharmacokinetics →

Part 11 — Food Animals Add a Second Receiver

When a medicine is used in an animal that produces food, veterinary pharmacology may also have to consider residues in meat, milk, eggs or other products.

The scientific question becomes larger:

help the animal + understand elimination + protect the food chain.

This is one reason withdrawal-time science and regulation matter in veterinary medicine.

Part 12 — Antimicrobials Add a Population Receiver

For antimicrobials, the target may be a bacterium or other microorganism rather than the animal’s own receptor. Drug exposure must be sufficient at the relevant site, but antimicrobial use also applies selection pressure to microbial populations.

This creates a route from veterinary pharmacology to antimicrobial resistance and One Health—but the pharmacological owner remains the question of exposure, effect and safe use in the animal.

How Do We Know?

Pharmacokinetic studies measure drug concentrations over time after controlled administration. Scientists use those data to estimate quantities such as clearance, volume of distribution, bioavailability and half-life. Pharmacodynamic studies relate concentration to biological effect.

Comparative studies then reveal where species behave similarly and where extrapolation fails.

Observation vs Inference

Observation: plasma concentration falls faster in species A than species B under defined conditions.
Inference: clearance or distribution differs.
Next test: measure metabolic pathways, renal elimination, protein binding or tissue distribution.

Pharmacology advances by decomposing the difference rather than simply labelling one species “sensitive.”

Common Misconceptions

Misconception	Better model
A smaller animal only needs proportionally less of a human medicine.	Species biology can change both drug exposure and toxicity.
mg/kg makes doses equivalent.	It normalises body mass, not metabolism, receptors or elimination.
A drug that is safe in dogs is safe in cats.	Dogs and cats can process the same compound differently.
Pharmacokinetics and pharmacodynamics are the same.	One describes concentration over time; the other describes biological effect.
The molecule alone determines half-life.	Half-life emerges from the molecule interacting with a particular organism.

Evidence Boundaries

species difference ≠ every individual of a species responds identically.
body-weight scaling ≠ complete pharmacological equivalence.
animal study ≠ automatic permission to extrapolate to another species.
mechanism knowledge ≠ safe self-prescribing.
educational pharmacology ≠ a dosing guide.

Checkpoint Questions

What does ADME stand for?
What is the difference between pharmacokinetics and pharmacodynamics?
Why can two species given the same mg/kg exposure differ?
Why can liver-enzyme differences change toxicity?
Why is half-life not a property of the molecule alone?
How can kidney disease alter drug exposure?
Why do food-producing animals create an additional pharmacology problem?
Why are allometric models useful but limited?

Answer key

Absorption, distribution, metabolism and excretion.
Pharmacokinetics describes what the body does to the drug; pharmacodynamics describes what the drug does to the body or target organism.
Species can differ in anatomy, enzymes, transporters, elimination and receptors.
Metabolism can detoxify, activate or produce reactive metabolites.
Observed persistence depends on both drug characteristics and organism physiology.
Reduced elimination can increase or prolong exposure.
Residues and food safety may have to be considered alongside animal health.
They describe broad scaling relationships but cannot replace species-specific biology.

Edge Science — Can We Predict a Drug in a Species Never Tested?

Modern comparative pharmacology uses physiologically based pharmacokinetic models, genomic information, enzyme-expression data, organ physiology and cross-species scaling to predict drug behaviour.

These models can narrow uncertainty, especially in rare or difficult-to-study species. But a model remains a model until its predictions are checked against appropriate evidence.

prediction can reduce ignorance; validation tells us whether the reduction was real.

Veterinary World Direction Graph

Species-specific pharmacology → comparative physiology → liver metabolism → kidney elimination → receptors → toxicology → anaesthesia → antimicrobial stewardship → food safety → wildlife medicine → aquatic-animal medicine.

Teaching Guide for Parents, Tutors and Teachers

For the people who teach because somebody depends on them.

Begin with a deliberately tempting wrong model: “If a medicine dose is adjusted per kilogram, why shouldn’t the same rule work for every animal?”

Let the learner propose body size as the whole answer. Then open the hidden dimensions one by one: gut → blood → liver → kidney → receptor → time.

amount given is only the beginning of the drug’s journey.

The goal is not memorising drug names. It is understanding why veterinary pharmacology must be comparative, mechanistic and evidence-based.

Research Sources and Further Reading

Educational boundary: This page explains comparative drug science only. It is not a medicine-selection or dosing guide. Never give an animal a human or veterinary medicine on the basis of this educational material; individual treatment decisions belong to an appropriately qualified veterinarian.

eduKate Singapore

eduKate Learning Manual: Species-Specific Pharmacology | Why the Same mg/kg Dose Is Not the Same Drug Experience Across Animals